Published in Cancer Weekly, February 22nd, 2011
KCCC pioneered this unique type of tumor conference in its local health care community and is experiencing growing support and attendance from area physicians.
Under the leadership of KCCC's Larry Geier, M.D., lead physician for KCCC's G.R.E.A.T. (Genetic Risk Evaluation and Testing) Program, the KCCC Genetic Tumor Conference takes a look...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.